期刊
EXPERT REVIEW OF VACCINES
卷 15, 期 11, 页码 1449-1462出版社
TAYLOR & FRANCIS LTD
DOI: 10.1080/14760584.2016.1188009
关键词
Silica particles; particulate antigen; immunogenicity; adjuvanticity; humoral response; cellular response; administration route; mucosal vaccination
类别
资金
- Centro de Investigaciones en Optica [INFR-2014-01-225843, CB-153161]
- PROFOCIE [2014-CA-213]
- PRODEP [FUNCTIONAL MATERIALS NETWORK]
- CONACYT/Mexico CONACYT [INFR-2014-01-225843, CB-153161]
- PROFOCIE
- PRODEP
Introduction: Although vaccination has prevented millions of deaths, the development of highly immunogenic subunit vaccines is still required. Since the number of adjuvants approved for human use is limited, the new paths for the development of delivery vehicles offered by nanotechnology are of key relevance.Areas covered: Herein, the potential of silica nanoparticles (SP) as both adjuvants and vaccine delivery vehicles is discussed based on the analysis of the current biomedical literature.Expert commentary: SP are reported not only as biodegradable and biocompatible material but also as easy to modify and with a low production cost. Additionally, several reports suggest that SP enhance the immune response. Therefore, SP are a promising delivery vehicle and/or adjuvant in vaccines. However, knowledge on the industrial production and specific aspects of immunity are still required.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据